P3.01-48 The Efficiency of Low-Dose Apatinib in Treatment of Advanced Lung Squamous Cell Carcinoma
Yuming Jia(Second People’s Hospital of Yibin), Yansheng Jiang(North Sichuan Medical University), Tao Li(Second People’s Hospital of Yibin), Lijun Qiu(Harvard University), Kaijian Lei(Second People’s Hospital of Yibin), Ming Jiang(Second People’s Hospital of Yibin), Mingming Hu(Beijing Normal University), X. Zhang(Second People’s Hospital of Yibin), Jie-Xian Jiang(Shanghai Academy of Agricultural Sciences), Yuan Qiu(Sun Yat-sen University), Ludi Du(Second People’s Hospital of Yibin), Shenglin Wang(Jiangxi Agricultural University), W. Ye(North Sichuan Medical University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College)
Cited by 1
Related Papers
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
|Journal of Clinical Oncology|2022|177